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Abstract
Aims: We evaluated the relationship between distribution of lesions in coronary tree and atherosclerotic renal artery stenosis (RAS).
Methods and results: Data collected prospectively on 500 consecutive patients who underwent simultaneous renal angiography 
­following­coronary­angiography.­Overall­prevalence­of­RAS­was­26.2%­(131­patients).­Significant­($50% luminal diameter stenosis) 
RAS­was­present­in­70­patients­(14%).­In­346­individuals­of­the­study­population,­significant­CAD­was­present­(69.2%).­Significant­
RAS was more common (18.4%) in this group. Older age, higher intra-arterial systolic blood pressure (SBP) and pulse pressure (PP) 
at­the­time­of­catheterization,­and­3-vessel­coronary­artery­disease­(CAD)­were­associated­with­significant­RAS­in­univariate­analysis.­
Relationship­between­involved­locations­of­coronary­arteries­[Left­anterior­descending­(LAD),­left­circumflex­(LCX),­Right­Coronary­
Artery­(RCA),­and­their­ostio-proximal­portions]­and­RAS­were­significant­except­for­left­main­(LM)­disease.­In­multivariate­model,­
age­more­than­62­years,­SBP­greater­than­150­mmHg,­PP­in­excess­of­60­mmHg­and­RCA­involvement­were­independent­predictors­of­
significant­RAS.
Conclusion:­ Simultaneous­ renal­ angiography­ following­ coronary­ angiography­might­ be­ justified­ in­ patients­with­ significant­RCA­
 disease who are older with increased levels of intra-arterial SBP and PP.
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Introduction
Atherosclerotic renal artery stenosis (RAS) is an 
important and frequently unrecognized contributor to 
refractory hypertension (HTN), ischemic nephropa-
thy, and cardiac destabilization syndromes (unstable 
angina,­flash­pulmonary­edema,­and­decompensated­
heart failure).1–5 Atherosclerotic RAS is a progressive 
disease leading to renal atrophy over time and chronic 
kidney disease despite control of HTN.6–13
Presence and severity of incidental RAS is an 
independent predictor of mortality in  atherosclerotic 
patients regardless of the mode of treatment of 
 underlying coronary artery disease.13–15
The prevalence of RAS has been reported to be in 
the range of 20–30 percent in high risk populations 
including patients with known atherosclerotic vascu-
lar disease elsewhere.16–18 In these patients invasive 
screening for RAS is highly cost-effective especially 
when done at the time of another invasive diagnostic 
procedure like cardiac catheterization, and may affect 
treatment strategies.19
Atherosclerosis is a diffuse process but affects 
certain regions of the vascular bed preferentially. 
The­association­between­extent­and­severity­of­CAD­
and RAS has been well established in most previous 
studies,12–14 but a few has been addressed the relation-
ship between the distribution of lesions in coronary 
tree and RAS.2,8,14
The­main­purpose­of­our­study­was­to­find­out­if­
any­association­exists.­ In­parallel,­we­evaluated­ the­
relationship between demographic variables, ath-
erosclerotic risk factors, renal function, and levels 
of intra-arterial pressures during catheterization and 
RAS.­In­conclusion,­we­postulated­that­these­findings­
might help decide in which group of patients screen-
ing­ renal­ angiography­ could­ be­ justified­ following­
coronary angiography.
Methods
Over a period of 12 months from November 2008, data 
collected prospectively on 500 consecutive patients 
who underwent simultaneous renal angiography 
 following coronary angiography in Shaheed Rajaie 
Cardiovascular­Medical,­and­Research­Center.
The indications for coronary and renal  angiography 
were at the discretion of the attending cardiologist. 
Demographic variables, laboratory data, and  history 
of atherosclerotic risk factors obtained from the 
patients’ medical record.
Patients considered hypertensive, if they had a 
 positive history of HTN who were under life style 
modification­ and/or­ medical­ treatment.­ Patients­
­considered­diabetic­ (DM)­ as­ either­ currently­ ­taking­
anti-diabetic medications or having more than 
one fasting plasma glucose (FPG) $126­ mg/dl­ on­
­laboratory­record.­Dyslipidemia­(DLP)­defined­if­the­
patient was under medical treatment for known dys-
lipidemia or any of the following laboratory criteria 
existed:­ Fasting­ low-density­ lipoprotein­ cholesterol­
(LDLc) $130­mg/dl,­ high-density­ lipoprotein­ cho-
lesterol (HDLc) #40­mg/dl­ in­men­and­#50­mg/dl­
in women or triglycerides $150­mg/dl.­Patients­con-
sidered having a history of smoking if they were 
 current or former smokers. A positive family history 
(FH)­established­based­on­a­known­history­of­CAD­
in­ a­ first­ degree­ relative­ male­ or­ female­ less­ than­
45­ and­ 55­ years­ respectively.­ Glomerular­ filtration­
rate­(GFR)­estimated­by­the­four­variable­modifica-
tion­of­diet­in­renal­disease­(MDRD)­equation­using­
plasma creatinine concentration, age, and gender.
According to the catheterization laboratory routine 
practice, all of these patients underwent abdominal 
aortography following coronary angiography using a 
pigtail catheter and 10–20 degrees straight left ante-
rior oblique (LAO) projection with a pump injector at 
a­rate­of­15­ml/sec.­In­those­patients­for­whom­it­was­
difficult­to­evaluate­the­degree­of­stenosis­via­aortog-
raphy, selective renal angiography also performed 
using a right judkins catheter and 0–20 degrees 
straight LAO projections with hand injection. 
By average, about 30–40 ml additional  contrast media 
were utilized which was either Ultravist-300  (Shering 
AG, Germany) or Visipaque-320 (GE Healthcare, 
 Ireland). No procedural related complications with 
either method reported. Data on contrast-induced 
nephropathy­(CIN)­was­not­available.
Significant­RAS­defined­if­luminal-narrowing­$50 
percent­was­present.­Coronary­disease­considered­ostio-
proximal­ if­ it­observed­before­first­diagonal­or­septal­
branch­in­LAD­artery,­before­first­sizable­obtuse­mar-
ginal­(OM)­branch­in­LCX­artery­and­before­the­first­
bend­ of­ the­ vessel­ in­RCA.­All­ angiograms­ digitally­
recorded­at­15­frames/sec­speed­and­interpreted­at­a­con-
sensus of two interventional cardiology fellowships.
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statistical Analysis
All collected data entered into a database and 
 subsequently analyzed using SPSS software 
version 15.0 for windows (SPSS). The relationship 
between­ RAS­ and­ other­ variables­ was­ examined­
using  student’s T-test for normal continuous vari-
ables­ and­ Chi-square­ test­ for­ categorical­ factors.­
Continuous­ variables­ that­ revealed­ significant­ rela-
tionship with RAS in univariate analysis categorized 
according to their distributions and entered into the 
multivariate­ model.­ Numerical­ variables­ expressed­
as mean ± standard deviation (SD) and categorical 
factors as percentages. Finally, independent predic-
tors of RAS derived by multivariate stepwise logistic 
­regression­analysis­and­expressed­as­odds­ratios­(OR)­
with­95%­confidence­interval­(CI).
P value of 0.05 or less considered statistically 
significant.
Results
In these cohort of patients, 264 (52.8%) were male 
with­mean­age­of­59.6­± 10.1 years and 236 (47.2%) 
were female with mean age of 60.8 ± 8.7 years. As 
for major atherosclerotic risk factors, 373 patients 
(74.6%)­had­HTN,­219­patients­(43.8%)­were­diabet-
ics,­445­individuals­(89%)­had­DLP,­108­(21.6%)­of­
them were smoker and 37 subjects (7.4%) had a posi-
tive FH (Table 1).
Prevalence of RAS with any degree of  stenosis 
was­ 26.2%­ (131­ patients).­ Significant­ RA­S­ was­
present in 70 patients (14%). It was unilateral in 
46­ patients­ (9.2%)­ and­ bilateral­ in­ 24­ (4.8%).­
In 26 (56%) of patients with unilateral disease, RAS 
was detected on left renal artery and in 20 patients 
(44%) right renal artery was involved. High-grades 
stenosis ($70% luminal narrowing) was present in 
45­ (9%)­of­ them­ [37­ (7.4%)­unilateral,­ 81­ (1.6%)­
bilateral,­18­(49%)­on­the­left­side­and­19­(51%)­on­
the­right]­(Fig. 1).
Patients with high-grade stenosis underwent 
renal artery stenting at the same setting or differed 
intervention for another session. Patients with mod-
erate (50%–70%) stenosis referred to nephrologists 
for further assessment about intervention or medi-
cal­ therapy.­ In­ 346­ individuals,­ significant­ CAD­
was­ present­ (69.2%).­ Significant­ RAS­ was­ more­
common (18.4%, P , 0.001) in this group. In the 
remaining 154 patients (30.8%) with either nor-
mal­ coronaries­ or­ insignificant­ CAD,­ six­ subjects­
(1.2%)­had­significant­RAS­in­which­all­were­high-
grade­ stenosis­ (bilateral­ in­ one).­ Significant­ RAS­
was more common in patients with three vessel 
CAD­compared­ to­ those­with­single­or­ two­vessel­
CAD.­Relationships­between­involved­locations­of­
coronary­arteries­and­RAS­were­significant­except­
for­LM­disease­(See­Table 2).
Patients­ with­ significant­ RAS­ were­ older­ com-
pared­ to­ those­ without­ significant­ disease.­ Neither­
sex­nor­other­ atherosclerotic­ risk­ factors­ showed­any­
association­with­significant­RAS.­Borderline­relation-
ships­observed­between­significant­RAS,­serum­crea-
tinine, and eGFR levels (Table 1). Because almost all 
patients were receiving statins, which has modest effect 
on HDLc (less than 10% increase in HDLc) compared 
Table 1. Patients’ clinical characteristics.
Variable Total  
(n = 500)
RAs $ 50% 
(n = 70)
RAs , 50% or 
normal (n = 430)
P value
Age 60.1 ± 9.4 63.1 ± 8.7 59.5 ± 9.9 0.003
Female (n) (%) 236 (47.2) 35 (50.0) 201 (46.7) 0.613
Male (n) (%) 264 (52.8) 35 (50.0) 229 (53.2) 0.613
hypertension (n) (%) 373 (74.6) 58 (82.8) 315 (73.2) 0.087
Diabetes mellitus (n) (%) 219 (43.8) 28 (40.0) 191 (44.0) 0.490
Dyslipidemia (n) (%) 445 (89.0) 65 (92.8) 380 (88.3) 0.266
Smoking (n) (%) 108 (21.6) 13 (18.5) 95 (22.0) 0.507
Positive family history (n) (%) 37 (7.4) 3 (4.2) 34 (7.9) 0.283
Serum creatinine (mg/dl) (mean ± SD) 1.10 ± 0.30 1.17 ± 0.37 1.09 ± 0.29 0.095
estimated gFr (ml/min/1.73 m2) (mean ± SD) 68.2 ± 20.5 64.8 ± 23.9 68.8 ± 19.9 0.050
hDLc (mg/dl) (mean ± SD) 38.6 ± 12.5 36.4 ± 1.2 39 ± 12.7 0.104
Abbreviation: rAS, renal artery stenosis.
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with­ other­ components­ of­ lipid­ profile,1 only this 
parameter statistically analyzed.
Mean­ intra-arterial­ systolic,­ diastolic­ and­ pulse­
pressures during catheterization were 172.8 ± 30.7 
vs. 161.6 ±­ 29.2­mmHg­ for­ systolic­BP,­ 85.1­± 14 
vs. 78.8 ± 21.5 for diastolic BP and 87.7 ± 23.7 vs. 
78.8 ±­21.5­for­pulse­pressure­with­significant­RAS­
compared to those without demonstrating a good 
relationship between systolic and pulse pressures but 
not diastolic BP and RAS.
At the end, by multivariate logistic regression 
analysis­age­more­ than­62­years­ (OR­2.12;­95%­CI­
1.16 to 3.48, P = 0.013), SBP greater than 150 mmHg 
(OR =­ 3.19;­ 95%­CI­ 1.57­ to­ 6.46,­P = 0.001), PP 
in­excess­of­60­ (OR­=­3.82;­95%­CI­1.11­ to­13.09,­
P =­ 0.033)­ and­ RCA­ involvement­ (OR­ = 3.76; 
95%­CI­1.89­to­7.48,­P , 0.001) were independent 
­predictors­ of­ ­significant­ RAS.­ LAD­ artery­ ­disease­
showed­ borderline­ significance­ (OR­ 2.12;­ 95%­
CI­0.94­to­4.79;­P =­0.069).­Results­of­the­models­for­
RAS $ 70% were almost similar to RAS $ 50% in 
both univariate and multivariate analyses.
Discussion
Prevalence of RAS with different severities and of 
bilateral RAS in this cohort of patients undergoing 
coronary angiography is within the range of most 
other studies.
Our study showed no difference in patients with sig-
nificant­RAS­compared­to­those­without­with­respect­
to­major­ atherosclerotic­ risk­ factors­ except­ for­ age.­
This­may­ reflect­ that­ traditional­ risk­ factors­ have­ a­
limited­potential­for­predicting­RAS.­­Dzielińska­et­al5 
and Wang et al12 were reported similar results, but 
considerable variability seen in many other studies.
In our study, age more than 62 years was an 
 independent predictor of RAS. In a number of  studies, 
this issue addressed with different thresholds, in 
which it was more than 60 years at a minimum.6,9 We 
also found borderline relationships between serum 
creatinine, eGFR levels, and RAS. In most stud-
ies­ reduced­ levels­ of­ eGFR­ (specifically­ less­ than­
60­ml/min/1.73­m2) discovered to be an independent 
predictor­of­significant­RAS.
Bearing in mind that not all patients with even 
severe RAS have uncontrolled HTN, renal fail-
ure or other clinical clues1,12 and the fact that well 
proven anti-atherothrombotic medications which 
block  rennin-angiotensin system may act as a two 
edged­ sword­ in­ the­ presence­ of­ significant­ but­
Table 2. Catheterization characteristics.
Variable Total  
(n = 500)
RAs $ 50 
(n = 70)
RAs , 50% or  
normal (n = 430)
P value
Significant CAD 346 (69.2) 64 (91.4) 282 (65.5) ,0.001
extent of CAD 
 normal coronary or minimal CAD 
 1VD 
 2VD 
 3VD
 
154 (30.8) 
77 (15.4) 
102 (20.4) 
167 (33.4)
 
6 (8.5) 
7 (48.5) 
17 (24.2) 
40 (57.1)
 
148 (34.4) 
70 (37) 
85 (19.5) 
127 (29.5)
 
,0.001 
0.213 
0.424 
,0.001
LAD 311 (62.2) 60 (85.7) 251 (58.3) ,0.001
LCX 242 (48.4) 47 (67.1) 195 (45.3) 0.001
rCA 229 (45.8) 54 (77.1) 175 (40.6) ,0.001
Ostio-proximal LAD 164 (32.8) 32 (45.7) 132 (30.6) 0.014
Ostio-proximal LCX 86 (17.2) 20 (28.5) 66 (15.3) 0.007
Ostio-proximal rCA 111 (22.2) 25 (35.7) 86 (20) 0.003
Left main disease 26 (5.2) 6 (8.5) 20 (4.6) 0.171
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Figure 1. Severity and sidedness (left, right, and bilateral) of renal artery 
lesions.
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 clinically unsuspected bilateral RAS1,3 underscores 
the need to step beyond traditional screening for 
RAS.­ ­Additionally­ hemodynamically­ significant­
RAS may have several deleterious systemic effects 
through activating this system, which may acceler-
ate atherogenesis and contribute to cardiovascular 
events.13,14
There was a good relationship between  intra-arterial 
systolic and pulse pressures and RAS, which is in agree-
ment­with­study­of­Weber-Mzell­et­al8 and Rihal et al.18 
In our study, systolic BP above 150-mmHg and pulse 
pressure­in­excess­of­60­mmHg­found­to­be­indepen-
dent­predictors­of­significant­RAS.­Wide­pulse­pres-
sure­may­simply­reflect­more­advanced­arteriosclerosis­
and renal disease and in a recent published study of 
Dieter et al,20 pulse pressure .100 mmHg was shown 
a powerful predictor of poor outcome following renal 
angioplasty­and­stenting.­We­found­highly­significant­
relationships between atherosclerotic involvement 
of­LAD,­LCX,­and­RCA­and­RAS,­which­remained­
significant­in­their­ostio-proximal­segments;­this­was­
not­true­for­significant­LM­disease.­As­for­number­of­
coronaries­involved,­patients­with­three­vessels­CAD­
showed strong relationship with RAS and those with 
normal­coronaries­or­insignificant­CAD­had­a­potent­
negative association with RAS. Interestingly in mul-
tivariate­model,­three­vessels­CAD­no­longer­seen­as­
an­independent­predictor­of­RAS­while­RCA­involve-
ment was a strong independent predictor of RAS and 
LAD artery disease showed borderline  relationship. 
As far as we know this independent relationship 
between­ atherosclerotic­disease­of­RCA­and­ signifi-
cant RAS not been reported before.
The predilections of certain sites in vascular sys-
tem to develop atheroma are clear.1 Atherosclerotic 
RAS predominantly affects the aorto-ostial segment,1 
but relationship between distribution of coronary 
artery lesions and segments involved has not been 
addressed­extensively.
In­ a­ study­ by­ Weber-Mzell­ et­ al,8­ LAD,­ LCX,­
and­ RCA­ stenosis­ were­ more­ frequent­ in­ patients­
with­ ­significant­ RAS­ but­ in­ multivariate­ analysis,­
 having .2­significant­coronary­lesions­recognized­as­
an  independent predictor of RAS. In another study 
by­Conlon­ et­ al,14 LAD disease was more frequent 
in patients with RAS $ 75%. There was no relation-
ship between  anatomical  distribution of coronary 
artery­lesions­(proximal,­mid­or­distal­portions)­and­
RAS in a study by Danesh et al,2 but two and 3-vessel 
 coronary disease reported as an independent predic-
tor­of­significant­RAS.
Although the therapeutic implications of inciden-
tally detected RAS has been remained controversial 
until now21 it may be valuable to be aware of this 
condition given the progressive nature of the disease, 
the precautions in prescribing angiotensin antagonists 
and possibly the need to revascularization in appro-
priately selected cases.
Given the considerable drawbacks of nonin-
vasive imaging techniques1,2,13 and safety of renal 
angiography13,16,17 recognizing potential candidates 
for screening of RAS based on readily available vari-
ables at the time of cardiac catheterization is important 
from a practical point of view. Patients with inciden-
tal RAS may deserve aggressive medical treatment 
and more close follow-up.
conclusion
Simultaneous renal angiography at the time of cor-
onary­ angiography­ might­ be­ justified­ in­ patients­
older than 62 years, with increased intra-arterial 
systolic pressure ($150 mmHg) and pulse pressure 
($60)­and­RCA­disease­in­the­absence­of­traditional­
 clinical clues.
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